A preclinical study reports a platform for the generation of dendritic cell-derived nanovesicles with enhanced immunostimulatory function, which demonstrate promising antitumoural activity in mouse models and might overcome some of the shortcomings of early-generation dendritic cell nanovaccines.
Michel Bierlaire, Timothy Michael Hillel, Janody Pougala
Corentin Jean Dominique Fivet, Pierluigi D'Acunto, Jonas Warmuth
, , , , ,